FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014016859> ?p ?o ?g. }

• W2014016859 endingPage "142" @default.
• W2014016859 startingPage "134" @default.
• W2014016859 abstract "Given the close interaction between tumor cells and stromal cells in the tumor microenvironment (TME), TME-targeted strategies would be promising for developing integrated cancer immunotherapy. Cancer-associated fibroblasts (CAFs) are the dominant stromal component, playing critical roles in generation of the pro-tumorigenic TME. We focused on the immunosuppressive trait of CAFs, and systematically explored the alteration of tumor-associated immune responses by CAF-targeted therapy. C57BL/6 mice s.c. bearing syngeneic E.G7 lymphoma, LLC1 Lewis lung cancer, or B16F1 melanoma were treated with an anti-fibrotic agent, tranilast, to inhibit CAF function. The infiltration of immune suppressor cell types, including regulatory T cells and myeloid-derived suppressor cells, in the TME was effectively decreased through reduction of stromal cell-derived factor-1, prostaglandin E2 , and transforming growth factor-β. In tumor-draining lymph nodes, these immune suppressor cell types were significantly decreased, leading to activation of tumor-associated antigen-specific CD8(+) T cells. In addition, CAF-targeted therapy synergistically enhanced multiple types of systemic antitumor immune responses such as the cytotoxic CD8(+) T cell response, natural killer activity, and antitumor humoral immunity in combination with dendritic cell-based vaccines; however, the suppressive effect on tumor growth was not observed in tumor-bearing SCID mice. These data indicate that systemic antitumor immune responses by various immunologic cell types are required to bring out the efficacy of CAF-targeted therapy, and these effects are enhanced when combined with effector-stimulatory immunotherapy such as dendritic cell-based vaccines. Our mouse model provides a novel rationale with TME-targeted strategy for the development of cell-based cancer immunotherapy." @default.
• W2014016859 created "2016-06-24" @default.
• W2014016859 creator A5003022193 @default.
• W2014016859 creator A5008254122 @default.
• W2014016859 creator A5019218267 @default.
• W2014016859 creator A5032612716 @default.
• W2014016859 creator A5054511414 @default.
• W2014016859 creator A5059141673 @default.
• W2014016859 creator A5070036928 @default.
• W2014016859 creator A5082349468 @default.
• W2014016859 date "2015-01-16" @default.
• W2014016859 modified "2023-10-09" @default.
• W2014016859 title "Cancer‐associated fibroblast‐targeted strategy enhances antitumor immune responses in dendritic cell‐based vaccine" @default.
• W2014016859 cites W1549752678 @default.
• W2014016859 cites W1612749618 @default.
• W2014016859 cites W1904470742 @default.
• W2014016859 cites W1968150533 @default.
• W2014016859 cites W1968893400 @default.
• W2014016859 cites W1972274031 @default.
• W2014016859 cites W1988136775 @default.
• W2014016859 cites W1994382025 @default.
• W2014016859 cites W1995481385 @default.
• W2014016859 cites W1998653903 @default.
• W2014016859 cites W2002145465 @default.
• W2014016859 cites W2002689409 @default.
• W2014016859 cites W2002879831 @default.
• W2014016859 cites W2005203470 @default.
• W2014016859 cites W2013404515 @default.
• W2014016859 cites W2013706060 @default.
• W2014016859 cites W2028668619 @default.
• W2014016859 cites W2031694561 @default.
• W2014016859 cites W2038475311 @default.
• W2014016859 cites W2040532846 @default.
• W2014016859 cites W2043503111 @default.
• W2014016859 cites W2044935670 @default.
• W2014016859 cites W2059688175 @default.
• W2014016859 cites W2060077121 @default.
• W2014016859 cites W2078502914 @default.
• W2014016859 cites W2084355281 @default.
• W2014016859 cites W2091041835 @default.
• W2014016859 cites W2101037339 @default.
• W2014016859 cites W2103816526 @default.
• W2014016859 cites W2107336310 @default.
• W2014016859 cites W2110355766 @default.
• W2014016859 cites W2120407692 @default.
• W2014016859 cites W2130870648 @default.
• W2014016859 cites W2135907850 @default.
• W2014016859 cites W2149142217 @default.
• W2014016859 cites W2150678612 @default.
• W2014016859 cites W2155194658 @default.
• W2014016859 cites W2156820203 @default.
• W2014016859 cites W2163376862 @default.
• W2014016859 cites W2168428587 @default.
• W2014016859 doi "https://doi.org/10.1111/cas.12584" @default.
• W2014016859 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4399032" @default.
• W2014016859 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25483888" @default.
• W2014016859 hasPublicationYear "2015" @default.
• W2014016859 type Work @default.
• W2014016859 sameAs 2014016859 @default.
• W2014016859 citedByCount "73" @default.
• W2014016859 countsByYear W20140168592015 @default.
• W2014016859 countsByYear W20140168592016 @default.
• W2014016859 countsByYear W20140168592017 @default.
• W2014016859 countsByYear W20140168592018 @default.
• W2014016859 countsByYear W20140168592019 @default.
• W2014016859 countsByYear W20140168592020 @default.
• W2014016859 countsByYear W20140168592021 @default.
• W2014016859 countsByYear W20140168592022 @default.
• W2014016859 countsByYear W20140168592023 @default.
• W2014016859 crossrefType "journal-article" @default.
• W2014016859 hasAuthorship W2014016859A5003022193 @default.
• W2014016859 hasAuthorship W2014016859A5008254122 @default.
• W2014016859 hasAuthorship W2014016859A5019218267 @default.
• W2014016859 hasAuthorship W2014016859A5032612716 @default.
• W2014016859 hasAuthorship W2014016859A5054511414 @default.
• W2014016859 hasAuthorship W2014016859A5059141673 @default.
• W2014016859 hasAuthorship W2014016859A5070036928 @default.
• W2014016859 hasAuthorship W2014016859A5082349468 @default.
• W2014016859 hasBestOaLocation W20140168591 @default.
• W2014016859 hasConcept C121608353 @default.
• W2014016859 hasConcept C126322002 @default.
• W2014016859 hasConcept C154317977 @default.
• W2014016859 hasConcept C167672396 @default.
• W2014016859 hasConcept C16930146 @default.
• W2014016859 hasConcept C179185449 @default.
• W2014016859 hasConcept C202751555 @default.
• W2014016859 hasConcept C203014093 @default.
• W2014016859 hasConcept C2776090121 @default.
• W2014016859 hasConcept C2776107976 @default.
• W2014016859 hasConcept C2777701055 @default.
• W2014016859 hasConcept C2778170410 @default.
• W2014016859 hasConcept C2780674031 @default.
• W2014016859 hasConcept C502942594 @default.
• W2014016859 hasConcept C55493867 @default.
• W2014016859 hasConcept C55721878 @default.
• W2014016859 hasConcept C71924100 @default.
• W2014016859 hasConcept C86803240 @default.
• W2014016859 hasConcept C8891405 @default.

• next